This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

7 Stocks Under $10 Soaring Higher


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Theragenics (TGX) is a medical device company, manufactures, markets, and sells disposable devices and radioactive seeds to the surgical products and cancer treatment markets. This stock is trading up 17.6% to $2.07 in recent trading.

Today's Range: $2.02-$2.10

52-Week Range: $1.18-$1.94

Volume: 580,000

Three-Month Average Volume: 35,697

Shares of TGX are soaring today after the company said it plans to repurchase up to $10 million worth of its shares in a modified Dutch auction tender offer. Under the terms of the tender offer, Theragenics stockholders will have the opportunity to tender some or all of their shares at a price within a range of $2 to $2.40 per share.

>>5 Stocks Under $10 Headed Higher

From a technical perspective, TGX is gapping up big here with monster volume. This move has pushed the stock into breakout territory, since shares have moved above some near-term overhead resistance at $1.94.

Traders should continue to look for long-biased trades as long as the stock is trending above $1.94, and once it triggers its next major breakout. That major breakout will hit once TGX takes out some past overhead resistance at $2.29 with high volume. Look for a sustained move or close above $2.29 with volume that's near or above 35,697 shares. If we get that action soon, then TGX could hit $3 in the near future. On the flipside, I would avoid any long grades if TGX trades back below $1.94 with high-volume.
3 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ELX $7.99 0.00%
ARNA $1.58 0.00%
NSU $3.36 1.50%
MUX $2.57 7.10%
AAPL $92.59 -0.70%


Chart of I:DJI
DOW 17,590.58 -70.13 -0.40%
S&P 500 2,042.16 -8.47 -0.41%
NASDAQ 4,689.8610 -27.2330 -0.58%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs